The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
NIHR Journals Library
2010-10-01
|
| Series: | Health Technology Assessment |
| Online Access: | https://doi.org/10.3310/hta14suppl2/04 |